Drug Profile
Tamsulosin controlled-release - Shiner Pharm
Alternative Names: HanlosinLatest Information Update: 11 Dec 2021
Price :
$50
*
At a glance
- Originator Shiner Pharm Corp
- Class Amines; Phenyl ethers; Small molecules; Sulfonamides
- Mechanism of Action Alpha-1a adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Benign prostatic hyperplasia
Most Recent Events
- 11 Feb 2019 Chemical structure information added